Adicet Bio, Inc.
ACET
NASDAQ·Healthcare·Biotechnology·Mkt cap $89.6M
$9.59
▲ +1.70%
P/E
—
Mkt Cap
$89.6M
52-Wk Range
$6.01–$17.44
52-Week Range
$6.01 - $17.44
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 21.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary allogeneic gamma delta T cell platform enabling off-the-shelf therapeutics
- Unique innate and adaptive dual anti-tumor immune mechanism
- Lower manufacturing costs and improved scalability versus autologous CAR-T competitors
- First-mover advantage in clinical-stage gamma delta CAR-T development
Bear Case
1 risk
- Above-average volatility (beta 1.6).
Growth
Stable outlook
Phase I clinical trial progression of ADI-001 for non-Hodgkin's lymphoma
Value
Deep value opportunity - significant discount to Biotech & Therapeutics peers
Momentum
Hot
+32.1% over 3m
Quality
Loss-making
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying ACET right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of -$1.99 vs -$1.69 consensus (-17.8% surprise).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-17.8%
Revenue trend · last 8Q
—
—
—
—
—
—
—
—
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$0
$0
$0
$0
$0
$0
$0
$0
Margins · last 8Q
No margin history available.
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Mar 23, 2026
vs Industry
How ACET stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related